AZIYO BIOLOGICS, INC. (AZYO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	10-K	10-K	8-K	S-1/A
Assets
Current assets:
Cash	17.0	30.4	39.2	2.6
Accounts receivable, net of credit loss reserve of $921 and $87, respectively	6.8	6.0	7.2	7.2
Inventory	10.1	9.6	10.1	7.2
Receivables of FiberCel litigation costs	13.8
Prepaid expenses and other current assets	3.0	1.5	2.9	1.4
Total current assets	50.7	47.4	59.7	18.4
Property and equipment, net	1.4	1.2	1.2	1.0
Intangible assets, net	15.1	18.5	21.9	25.3
Operating lease right-of-use assets and other	1.7	0.1	0.1	0.1
Total assets	68.8	67.2	82.8	44.8

Liabilities and Stockholders' Deficit
Current liabilities:
Accounts payable	2.3	1.6	2.1
Accrued expenses and other current liabilities	17.4	6.4	6.3
Payables to tissue suppliers	3.2	2.5	2.3
Current portion of revenue interest obligation	9.0	2.8	2.8
Contingent liability for FiberCel litigation	17.4
Current operating lease liabilities and other	0.7	0.0
Total current liabilities	42.6	26.0	26.8	18.3
Long-term debt	24.3	10.4	17.8
Long-term revenue interest obligation	5.9	16.5	16.6
Long-term operating lease liabilities	1.0
Other long-term liabilities	0.1	0.7	0.8
Total liabilities	73.9	53.6	62.0	55.4

Commitments and contingencies (Note 8)
Stockholders' equity (deficit):
Common stock
Additional paid-in capital	132.9	118.6	101.1	1.8
Accumulated deficit	-138.0	-105.1	-80.3	-56.9
Total stockholders' deficit	-5.0	13.5	20.8	-55.1
Total liabilities and stockholders' deficit	68.8	67.2	82.8